Cardiotoxicity after cancer treatment: a process map of the patient treatment journey.

ABSTRACT:

Background/aim

Cardiotoxicity is a potential complication of anticancer therapy. While guidelines have been developed to assist practitioners, an effective, evidence based clinical pathway for the treatment of cardiotoxicity has not yet been developed. The aim of this study was to describe the journey of patients who developed cardiotoxicity through the healthcare system in order to establish baseline data to inform the development and implementation of a patient-centred, evidence-based clinical pathway.

Methods

Mixed-methods design with quantitative and qualitative components using process mapping at 3 large medical centres in 2 states between 2010 and 2015.

Results

Fifty (50) confirmed cases of cardiotoxicity were reviewed (39 medical record reviews, 7 medical recor

SUBMITTER: Clark RA 

PROVIDER: S-EPMC7048085 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature